Over the course of the past few trading sessions, there has been a bit of a rebound in the Zomedica (NYSEAMERICAN:ZOM) stock.
Since the end of January, the stock had gone below $1 dollar share but not it has managed to regain that level again. That being said, experts do not believe that the latest recovery in the stock is going to last for long.
In addition to that, it is necessary to note that Zomedica is a ‘meme stock’ and much of the gains in the past were garnered due to the action of investors from social media platforms.
Experts believe that although the stock has crashed by as much as 65% from its highest levels, the valuation is still quite expensive. Hence, there is a school of thought that investors try to figure out its true value, there is going to be further selling pressure on the stock.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.